Randomized, Double -Blind, Placebo Controlled, Trial to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU
et al., NCT04558424, NCT04558424, Sep 2021
Vitamin C for COVID-19
6th treatment shown to reduce risk in
September 2020, now with p = 0.00000002 from 75 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols
combine treatments.
6,300+ studies for
210+ treatments. c19early.org
|
Estimated 50 patient vitamin C late treatment RCT with results not reported over 4 years after estimated completion.
Study covers vitamin C and zinc.
1.
Liu et al., Clinical Efficacy of Megadose Vitamin C in Severe and Critical Ill COVID-19 Patients (CEMVISCC): A Multicenter, Randomized, Single-blind, Placebo-controlled Clinical Trial, NCT05694975, clinicaltrials.gov/study/NCT05694975.
2.
Boukef et al., Melatonin, Vitamins and Minerals Supplements for the Treatment of Covid-19 and Covid-like Illness: Results of a Prospective, Randomised, Double-blinded Multicentre Study, NCT05670444, clinicaltrials.gov/study/NCT05670444.
3.
Lamontagne et al., Lessening Organ Dysfunction With VITamin C - COVID, NCT04401150, clinicaltrials.gov/study/NCT04401150.
4.
Galindo et al., High-dose Intravenous Vitamin C (HDIVC) as Adjuvant Therapy in Critical Patients With Positive COVID-19. A Pilot Randomized Controlled Dose-comparison Trial., NCT05029037, clinicaltrials.gov/study/NCT05029037.
Sharmin et al., 1 Sep 2021, Double Blind Randomized Controlled Trial, placebo-controlled, Bangladesh, trial NCT04558424 (history).
Contact: elora.sharmin@bsmmu.edu.bd.

